DR. RECKEWEG R37 Colinteston

Product NDC: 53346-1337
11-digit product format: 533461337
Labeler code: 53346
Product ID: 53346-1337_c6d67ab3-1dfb-47b9-ab30-98b3daa41391
Type: HUMAN OTC DRUG
Nonproprietary name: Alumina 12X, Bryonia 4X, Colocynthis 4X, Lachesis mutus 30X, Lycopodium clavatum 4X, Mercurius corrosivus 8X, Nux vomica 6X, Plumbum aceticum 12X, Sulphur 12X
Dosage form: LIQUID
Route: ORAL
Labeler: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 1986-06-01
Marketing end: 0000-00-00
Substance: ALUMINUM OXIDE; BRYONIA DIOICA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; STRYCHNOS NUX-VOMICA SEED; LEAD ACETATE; SULFUR
Active strength: 12 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53346-1337		I	Inactivated by FDA		2026-10-05
excluded package	package	53346-1337	53346-1337-5	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53346-1337-5	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53346-1337-5	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53346-1337-5	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53346-1337-5	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53346-1337-5	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53346-1337-5	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53346-1337-5	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53346-1337-5	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53346-1337-5	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53346-1337-5	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53346-1337-5	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53346-1337-5	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53346-1337-5	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53346-1337-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53346-1337-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53346-1337-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53346-1337-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53346-1337-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53346-1337-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53346-1337-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53346-1337-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53346-1337-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53346-1337-5	2020-01-31	C162847	48780-1	9d75b9d0-e002-f424-e053-dadaa90a57ce	DR. RECKEWEG R37 Colinteston

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53346-1337-5	DR. RECKEWEG R37 ColintestonCombination Product	50 mL in 1 BOTTLE	LIQUID	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ALUMINUM OXIDE	ACTIVE INGREDIENT	LMI26O6933	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
BRYONIA DIOICA ROOT	ACTIVE INGREDIENT	53UB5FH7CX	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CITRULLUS COLOCYNTHIS FRUIT PULP	ACTIVE INGREDIENT	23H32AOH17	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LACHESIS MUTA VENOM	ACTIVE INGREDIENT	VSW71SS07I	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LEAD ACETATE	ACTIVE INGREDIENT	RX077P88RY	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LYCOPODIUM CLAVATUM SPORE	ACTIVE INGREDIENT	C88X29Y479	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MERCURIC CHLORIDE	ACTIVE INGREDIENT	53GH7MZT1R	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE INGREDIENT	269XH13919	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ALUMINUM OXIDE	ACTIVE MOIETY	LMI26O6933	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
BRYONIA CRETICA SUBSP. DIOICA ROOT	ACTIVE MOIETY	53UB5FH7CX	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CITRULLUS COLOCYNTHIS FRUIT PULP	ACTIVE MOIETY	23H32AOH17	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LACHESIS MUTA VENOM	ACTIVE MOIETY	VSW71SS07I	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LEAD	ACTIVE MOIETY	2P299V784P	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LYCOPODIUM CLAVATUM SPORE	ACTIVE MOIETY	C88X29Y479	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MERCURIC CATION	ACTIVE MOIETY	ED30FJ8Y42	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE MOIETY	269XH13919	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SULFUR	ACTIVE MOIETY	70FD1KFU70	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53346-1337	DR. RECKEWEG R37 COLINTESTON COMBINATION PRODUCT (ALUMINA 12X, BRYONIA 4X, COLOCYNTHIS 4X, LACHESIS MUTUS 30X, LYCOPODIUM CLAVATUM 4X, MERCURIUS CORROSIVUS 8X, NUX VOMICA 6X, PLUMBUM ACETICUM 12X, SULPHUR 12X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1	Legacy NDC, 1 package rows	20130514_adde35b0-c6bf-47f2-bffb-7eb0d4318c13.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LMI26O6933	ALUMINUM OXIDE	1344-28-1	ALUMINUM OXIDE
53UB5FH7CX	BRYONIA DIOICA ROOT		BRYONIA DIOICA ROOT
23H32AOH17	CITRULLUS COLOCYNTHIS FRUIT PULP		CITRULLUS COLOCYNTHIS FRUIT PULP
VSW71SS07I	LACHESIS MUTA VENOM		LACHESIS MUTA VENOM
C88X29Y479	LYCOPODIUM CLAVATUM SPORE	8023-70-9	LYCOPODIUM CLAVATUM SPORE
53GH7MZT1R	MERCURIC CHLORIDE	7487-94-7	MERCURIC CHLORIDE
269XH13919	STRYCHNOS NUX-VOMICA SEED	8046-97-7	STRYCHNOS NUX-VOMICA SEED
RX077P88RY	LEAD ACETATE	6080-56-4	LEAD ACETATE
70FD1KFU70	SULFUR	7704-34-9	SULFUR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
53346-1337-5	53346133705	50 mL in 1 BOTTLE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DR. RECKEWEG R37 Colinteston	PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO	2013-04-08	HUMAN OTC DRUG LABEL	1